Abstract
A design for the perfusion of one (monoperfusion) or two (parallelperfusion) cotyledos of one placenta was developed for studies of the metabolism of the precursor steroid dehydroepiandrosterone (DHA). Several parameters are used as viability criteria: vascular resistance, glucose and oxygen consumption, lactate/pyruvate ratio, activity of lactate-dehydrogenase (LDH) in the perfusate, extent of perfusion bydye infusion, and morphological description by electron microscopy. A dosage of 2mg DHA with 2.5μCi 14C-radioactive labelled marker is given for testing the metabolizing capacity of the placenta. The labelled metabolites DHA, androstendione (A), testosterone (T), estrone (Oe 1), and estradiol-17β (Oe 2) are separated by thin-layer chromatography and measured by scanning and measurements of scraped radioactive spots by scintillation counting. The steroidogenesis isevaluated with the concentrations of Oe 1 at 15min (Oe 1.15′), Oe 1 + Oe 2at 90min (Oe tot, 90′), total aromatization rate (from perfusate and homogenate after 120 min). Results comparable to DHA are found using DHA-sulphate (DHA-S) as precursor, higher amounts of estrogens are metabolized from A. Mature placentas metabolize DHA in relation to the initial DHA concentration: optimal aromatization is found at 250–350 pmol DHA/ml/g, decreased aromatization at higher or lower concentrations. Oe 1 represents the main placental metabolite.
Similar content being viewed by others
References
Siiteri P.K., MacDonald P.C. The utilization of circulating dehydroisoandrosterone sulfate for estrogen synthesis during human pregnancy. Steroids 2: 713, 1963.
Diczfalusy E. Steroid metabolism in the foeto-placental unit. In: Pecile A., Finzi D. (Eds.), The Foetoplacental unit. Excerpta Medica Foundation, Amsterdam, 1969, p. 65.
Rech W. Untersuchungen über die Eigenstoffwechsel der menschlichen Placenta. Z. Biol. 80: 231, 1924.
Challier J.G., Schneider H., Dancis J. In vitro perfusion of human placenta. V. Oxygen-consumption. Am. J. Obstet. Gynecol. 126: 261, 1976.
Krantz K.E., Blakey J., Yoshida K., Romito J.A. Demonstration of viability of perfused human term placenta. Obstet. Gynecol. 37: 183, 1971.
Nesbitt R.E.L. Jr., Rice P.A., Rourke J.E. In vitro perfusion studies of the human placenta. III. The relationship between glucose utilization rates and concentrations. Gynecol. Invest. 4: 243, 1973.
Waldi D. Steroide. III. Die C21 -, C19- und C18- Steroide. In: Stahl E. (Ed.), Dünnschichtchromatographie. Springer-Verlag, Berlin, 1962, p. 266.
Ruh T.S. Simultaneous separation of estrogens and androgens using thin-layer chromatography. J. Chromatogr. 121: 82, 1976.
Thomas J.A., Varangot J. La survie du placenta humain perfuse aseptiquement. C.R. Acad. Sci. (D) (Paris) 228: 132, 1949.
Troen P., Gordon E.E. Perfusion studies of the human placenta. I. Effect of estradiol and human chorionic gonadotropin on citric acid metabolism. J. Clin. Invest. 37: 1516, 1958.
Varangot J., Cedard L., Yanotti S. Perfusion of the human placenta in vitro. Study of the biosynthesis of estrogens. Am. J. Obstet. Gynecol. 92: 534, 1965.
Cedard L., Varangot J., Yanotti S. Biosynthèse de l’oestriol dans les placentas humains perfusés in vitro: Formation à partir de certains stéroides neutres phenoliques hydroxylés sur le carbone. 16.C.R. Acad. Sci. (D) (Paris) 254: 3896, 1962.
Cedard L., Varangot J., Yanotti S. Biosynthèse et metabolisme des estrogènes dans le placenta humain perfusé ou incubé in vitro. II. Variation des réactions enzymatiques au fonction de l’age de la grossesse. Eur. J. Steroids 1: 287, 1966.
Cedard L. Placental perfusion in vitro. In: Diczalusy E. (Ed.), Karolinska symposia on research methods in reproductive endocrinology. 4th Symposium. Perfusion techniques. Karolinska Institutet, Stockholm, 1971, p. 331.
Levitz M., Condon G.P., Dancis J. The interconversion of estrone and estradiol in the perfused human placenta. Endocrinology 58: 376, 1956.
Krantz K.E., Panos T.C., Evans J. Physiology of maternal-fetal relationship through the extracorporal circulation of the human placenta. Am. J. Obstet. Gynecol. 83: 1214, 1962.
Panigel M. Comparative anatomical, physiological and pharmacological aspects of placental permeability and haemodynamics in the non-human primate placenta and in the isolated perfused human placenta. In: Pecile A., Finzi C. (Eds.), The foeto-placental unit. Excerpta Medica Foundation, Amsterdam, 1969, p. 279.
Nesbitt R.E.L. Jr., Rice P.A., Rourke J.E., Torresi V.F., Souchay A.M. In vitro perfusion studies of the human placenta. A newly designed apparatus for extracorporeal perfusion achieving dual closed circulation. Gynecol. Invest. 1: 185, 1970.
Schneider H., Panigel M., Dancis J. Tranfer across the perfusated human placenta of antipyrine, sodium and leucine. Am. J. Obstet. Gynecol. 114: 822, 1972.
Wolf A.S., Musch K., Speidel W., Strecker J.R., Lauritzen C. Steroid metabolism in the perfused human placenta. I. Metabolism of dehydroepiandrosterone sulfate. Acta Endocrinol. (Kbh.) 87: 181, 1978.
Panigel M. Morphological evaluation of perfused tissues. In: Diczfalusy, E. (Ed.), Karolinska symposia on research methods in reproductive endocrinology. 4th Symposium. Perfusion techniques. Karolinska-Institutet, Stockholm, 1971, p. 74.
Wolf A.S., Musch K., Frosch E. Description of placental vitality in perfusion studies by transmission electronmicroscopy. In preparation.
Ryan K. Biological aromatization of steroids. J. Biol. Chem. 234: 268, 1959.
Yates J., Oakey R. The role of 3β-hydrosteroid dehydrogenase-Isomerase in the conversion of dehydro-epiandrosterone to estrogens by a preparation of human placental microsomes in vitro. Steroids 19: 119, 1972.
Morato T., Lemus A.E., Gual C. Efficiency of dehydroepiandrosterone sulfate as an estrogen precursor. Steroids 59: 59, 1965.
Lamb E., Mancuso S., Dell’Acqua S., Wiquist N., Diczfalusy E. Studies on the metabolism of the C19 — steroids in the human feto-placental unit. 1. Neutral metabolites formed from dehydroepiandrosterone and dehydroepiandrosterone sulfate by the placenta at midpregnancy. Acta Endocrinol. (Kbh.) 55: 263, 1967.
Lehmann W.D., Lauritzen C., Schuhmann R. In vitro conversion of 14 C-DHA and androstenedione to estrogens by microsomes of placentas from normal, toxaemic, diabetic and postmature pregnancies. Acta Endocrinol. (Kbh.) 73: 771, 1973.
Lauritzen C. A clinical test for placental functional activity, using DHEA-sulfate and ACTH-injections in pregnant women. Acta Endocrinol. (Kbh.) (Suppl.) 119: 88, 1967.
Buster J.E., Abraham G.E., Kyle F.W., Marschall J.R. Serum steroid levels following a large intravenous dose of a steroid sulfate precursor during the second trimester of human pregnancy. I. Dehydroepiandrosterone sulfate. J. Clin. Endocrinol. Metab. 38: 1031, 1974.
Fraser I.S., Leask R., Drife L., Bacon L., Michie E. Plasma estrogen response to dehydroepiandrosterone sulfate injection in normal and complicated late pregnancy. Obstet. Gynecol. 47: 152, 1976.
Lauritzen C., Strecker J.R., Lehmann W.D. Dynamic tests of placental function: Some findings on the conversion of DHA-S to estrogens. In: Klopper, A. (Ed.), Plasma hormone assays in evaluation of fetal wellbeing. Churchill, Livingstone, 1976, p. 113.
Pupkin M.J., Nagay D.A., Mackenna J., Schomberg D.W., Crenshaw C. Jr. A physiologic model of the dehydroepiandrosterone to estrogen conversion system in the feto-placental unit. Am. J. Obstet. Gynecol. 25: 256, 1976.
Strecker J.R., killus C., Lauritzen Ch., Neumann B.K. The clinical value of the dehydroepiandrosterone-sulfate loading test in normal and pathologic pregnancies. Am. J. Obstet. Gynecol. 131: 239, 1978.
Bolte E., Manusco S., Erikson G., Wiquist N., Diczfalusy E. Studies on the aromatization of neutral steroids in pregnant women. I. Aromatization of C19 steroids by placentas perfused in situ. Acta Endocrinol. (Kbh.) 45: 535, 1964.
Klopper A., Varela-Torres R., Jandial V. Placental metabolism of dehydroepiandrosterone sulfate in normal pregnancy. Br. J. Obstet. Gynaecol. 83: 478, 1976.
Bergheim E., Oertel G.W. Effect of exogenous dehydroepiandrosterone sulfate on various enzymes and on steroid metabolism in the guinea-pig. J. Endocrinol. 70: 11, 1976.
Raineri R., Levy H.R. On the specificity of steroid interaction with the mammary glucose-6-phosphate dehydrogenase. Biochemistry 9: 2233, 1970.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolf, A.S., Musch, K., Breitig, D. et al. Metabolism of dehydroepiandrosterone (DHA) in the mature perfused human placenta (I). J Endocrinol Invest 5, 141–148 (1982). https://doi.org/10.1007/BF03349468
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349468